Tissue Regenix Group plc announces that it has received approval from the Irish Health Products Regulatory Authority ('HPRA'), allowing the Company to set up a logistics hub in Ireland for the distribution of its allograft products within the European Union ('EU'). The HPRA regulates medicines and devices in Ireland for the benefit of people and animals,inspecting companies and facilities which test, make or distribute health products to ensure that they comply with relevant standards and legislation. Tissue Regenix has also signed an exclusive distributor contract with Spineart España SLU ('Spineart') for the distribution of its allograft products in Spain.

Spineartis a privately held medical device company that operates in over 60 markets, focused on simplifying surgery by designing, developing and promoting safe and efficient solutions to spine surgeons, operating room teams and patients.